PAVmed Inc. — Director's Dealing 2023

Feb 3, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PAVmed Inc. (PAVM)
CIK: 0001624326
Period of Report: 2023-01-30

Reporting Person: Baxter Timothy E (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-01-30	Employee stock option (right to buy)	$.48	A	450000	Acquired	2033-01-30	Common stock (450000)	Direct

Footnotes

F1: One third of the option vests on March 31, 2023; the balance vests in eight equal quarterly installments, starting June 30, 2023.